Related Experiment Video
Updated: Jun 17, 2026
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Regulating A549 cells growth by ASO inhibiting miRNA expression
Ping-Yu Wang1, You-Jie Li, Shuai Zhang
1Department of Biochemistry and Molecular Biology, Institute of Medical Molecular Genetics, Binzhou Medical University, 264003 Yan Tai City, Shan Dong Province, People's Republic of China.
Molecular and Cellular Biochemistry
|January 6, 2010
Summary
Antisense oligonucleotides (ASOs) can inhibit oncogenic microRNAs (miRNAs) to induce lung cancer cell apoptosis. ASOs also enhance chemotherapy sensitivity, showing promise for lung cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- MicroRNAs (miRNAs) regulate critical cellular processes like proliferation and apoptosis.
- Dysregulation of miRNAs is implicated in cancer development and progression.
- Antisense oligonucleotides (ASOs) offer a strategy to modulate miRNA expression.
Purpose of the Study:
- To investigate the efficacy of ASOs in inhibiting specific miRNAs to induce apoptosis in A549 lung cancer cells.
- To determine the role of identified tumor suppressor and oncogenic miRNAs in regulating cancer-related genes.
- To evaluate the potential of ASOs in enhancing the sensitivity of lung cancer cells to chemotherapy.
Main Methods:
- Cell culture (A549, HBE, 293T cells) and treatment with ASOs.
- Assessment of cell proliferation and apoptosis using microscopy and biochemical assays.
- Quantitative analysis of miRNA and gene expression via real-time PCR and ELISA.
- Combination treatment of ASO-treated cells with anti-cancer drugs (cisplatin, demethylcantharidin).
Main Results:
- ASOs effectively inhibited target miRNA expression in A549 cells.
- miR-16, miR-17, miR-34a-c, and miR-125 were identified as tumor suppressor miRNAs.
- miR-20, miR-106, and miR-150 were identified as oncogenic miRNAs, regulating BCL-2, E2F1, E2F3, RB1, and P53.
- Co-treatment with ASOs targeting oncogenic miRNAs and chemotherapy drugs significantly reduced viable cell percentage.
Conclusions:
- ASOs targeting oncogenic miRNAs can effectively induce apoptosis in A549 lung cancer cells.
- ASO-mediated inhibition of oncogenic miRNAs enhances the sensitivity of lung cancer cells to chemotherapy.
- This approach holds significant therapeutic potential for lung cancer treatment.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...